USPH Net Receivables vs Deferred Long Term Liab Analysis

USPH Stock

USD 101.83 1.30 1.29%

US Physicalrapy financial indicator trend analysis is much more than just breaking down US Physicalrapy prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether US Physicalrapy is a good investment. Please check the relationship between US Physicalrapy Net Receivables and its Deferred Long Term Liab accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in US Physicalrapy. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey.

For more detail on how to invest in USPH Stock please use our How to Invest in US Physicalrapy guide.

Net Receivables vs Deferred Long Term Liab

Net Receivables vs Deferred Long Term Liab Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of US Physicalrapy Net Receivables account and Deferred Long Term Liab. At this time, the significance of the direction appears to have strong relationship.

The correlation between US Physicalrapy's Net Receivables and Deferred Long Term Liab is 0.68. Overlapping area represents the amount of variation of Net Receivables that can explain the historical movement of Deferred Long Term Liab in the same time period over historical financial statements of US Physicalrapy, assuming nothing else is changed. The correlation between historical values of US Physicalrapy's Net Receivables and Deferred Long Term Liab is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Receivables of US Physicalrapy are associated (or correlated) with its Deferred Long Term Liab. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Deferred Long Term Liab has no effect on the direction of Net Receivables i.e., US Physicalrapy's Net Receivables and Deferred Long Term Liab go up and down completely randomly.

Correlation Coefficient

0.68

Relationship Direction	Positive
Relationship Strength	Significant

View All Relationships

Net Receivables

Deferred Long Term Liab

Liabilities that are due after more than one year, including deferred tax liabilities and deferred revenue.

Most indicators from US Physicalrapy's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into US Physicalrapy current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in US Physicalrapy. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey.

For more detail on how to invest in USPH Stock please use our How to Invest in US Physicalrapy guide.As of now, US Physicalrapy's Enterprise Value Over EBITDA is increasing as compared to previous years. The US Physicalrapy's current Enterprise Value Multiple is estimated to increase to 17.58, while Selling General Administrative is projected to decrease to under 26.7 M.

	2021	2022	2023	2024 (projected)
Gross Profit	117.2M	112.0M	112.0M	117.6M
Total Revenue	495.0M	553.1M	604.8M	635.0M

Gross Profit Total Revenue

US Physicalrapy fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Long Term Debt Total	Non Currrent Assets Other	Non Current Liabilities Total	Short Term Debt	Intangible Assets	Good Will	Common Stock Total Equity	Common Stock
Total Assets		0.89	0.96	0.98	0.93	0.76	0.9	0.77	0.82	1.0	0.82	0.95	0.7	0.69	0.8	0.98	0.95	0.92	0.95	-0.41	0.96	0.93	0.99	-0.4	0.54	0.55
Other Current Liab	0.89		0.95	0.9	0.83	0.57	0.89	0.56	0.71	0.89	0.71	0.88	0.73	0.47	0.71	0.82	0.78	0.81	0.76	-0.24	0.75	0.83	0.85	-0.48	0.6	0.61
Total Current Liabilities	0.96	0.95		0.93	0.96	0.75	0.89	0.7	0.74	0.97	0.74	0.9	0.67	0.58	0.69	0.94	0.92	0.84	0.91	-0.39	0.89	0.96	0.93	-0.38	0.51	0.52
Total Stockholder Equity	0.98	0.9	0.93		0.87	0.63	0.89	0.67	0.89	0.96	0.89	0.93	0.75	0.7	0.88	0.93	0.91	0.97	0.89	-0.26	0.91	0.88	0.95	-0.46	0.6	0.61
Property Plant And Equipment Net	0.93	0.83	0.96	0.87		0.85	0.84	0.77	0.68	0.95	0.68	0.84	0.58	0.6	0.59	0.95	0.94	0.78	0.95	-0.49	0.92	0.99	0.91	-0.29	0.42	0.43
Net Debt	0.76	0.57	0.75	0.63	0.85		0.74	0.92	0.32	0.81	0.32	0.73	0.47	0.6	0.28	0.84	0.78	0.48	0.89	-0.84	0.85	0.82	0.81	-0.26	0.35	0.36
Retained Earnings	0.9	0.89	0.89	0.89	0.84	0.74		0.75	0.58	0.91	0.58	0.97	0.88	0.69	0.64	0.86	0.78	0.75	0.82	-0.44	0.82	0.8	0.89	-0.7	0.79	0.8
Accounts Payable	0.77	0.56	0.7	0.67	0.77	0.92	0.75		0.4	0.8	0.4	0.77	0.55	0.65	0.4	0.84	0.73	0.56	0.87	-0.85	0.86	0.73	0.82	-0.38	0.46	0.46
Cash	0.82	0.71	0.74	0.89	0.68	0.32	0.58	0.4		0.76	1.0	0.68	0.49	0.58	0.95	0.77	0.81	0.97	0.71	0.04	0.76	0.72	0.76	-0.2	0.34	0.35
Non Current Assets Total	1.0	0.89	0.97	0.96	0.95	0.81	0.91	0.8	0.76		0.76	0.95	0.7	0.68	0.75	0.98	0.94	0.88	0.96	-0.48	0.96	0.94	0.99	-0.4	0.54	0.55
Cash And Short Term Investments	0.82	0.71	0.74	0.89	0.68	0.32	0.58	0.4	1.0	0.76		0.68	0.49	0.58	0.95	0.77	0.81	0.97	0.71	0.04	0.76	0.72	0.76	-0.2	0.34	0.35
Net Receivables	0.95	0.88	0.9	0.93	0.84	0.73	0.97	0.77	0.68	0.95	0.68		0.86	0.73	0.74	0.9	0.83	0.84	0.87	-0.4	0.87	0.82	0.94	-0.64	0.74	0.75
Common Stock Shares Outstanding	0.7	0.73	0.67	0.75	0.58	0.47	0.88	0.55	0.49	0.7	0.49	0.86		0.69	0.59	0.63	0.55	0.65	0.58	-0.2	0.59	0.53	0.67	-0.9	0.98	0.98
Other Current Assets	0.69	0.47	0.58	0.7	0.6	0.6	0.69	0.65	0.58	0.68	0.58	0.73	0.69		0.61	0.72	0.74	0.69	0.72	-0.3	0.75	0.61	0.71	-0.59	0.63	0.64
Other Stockholder Equity	0.8	0.71	0.69	0.88	0.59	0.28	0.64	0.4	0.95	0.75	0.95	0.74	0.59	0.61		0.73	0.72	0.95	0.65	0.04	0.72	0.63	0.77	-0.32	0.45	0.46
Total Liab	0.98	0.82	0.94	0.93	0.95	0.84	0.86	0.84	0.77	0.98	0.77	0.9	0.63	0.72	0.73		0.97	0.87	0.99	-0.53	0.99	0.96	0.98	-0.33	0.47	0.48
Property Plant And Equipment Gross	0.95	0.78	0.92	0.91	0.94	0.78	0.78	0.73	0.81	0.94	0.81	0.83	0.55	0.74	0.72	0.97		0.88	0.96	-0.39	0.96	0.97	0.93	-0.24	0.38	0.39
Total Current Assets	0.92	0.81	0.84	0.97	0.78	0.48	0.75	0.56	0.97	0.88	0.97	0.84	0.65	0.69	0.95	0.87	0.88		0.82	-0.1	0.86	0.81	0.88	-0.36	0.5	0.51
Short Long Term Debt Total	0.95	0.76	0.91	0.89	0.95	0.89	0.82	0.87	0.71	0.96	0.71	0.87	0.58	0.72	0.65	0.99	0.96	0.82		-0.6	0.99	0.95	0.96	-0.29	0.42	0.43
Non Currrent Assets Other	-0.41	-0.24	-0.39	-0.26	-0.49	-0.84	-0.44	-0.85	0.04	-0.48	0.04	-0.4	-0.2	-0.3	0.04	-0.53	-0.39	-0.1	-0.6		-0.56	-0.45	-0.51	0.11	-0.14	-0.14
Non Current Liabilities Total	0.96	0.75	0.89	0.91	0.92	0.85	0.82	0.86	0.76	0.96	0.76	0.87	0.59	0.75	0.72	0.99	0.96	0.86	0.99	-0.56		0.93	0.97	-0.3	0.43	0.44
Short Term Debt	0.93	0.83	0.96	0.88	0.99	0.82	0.8	0.73	0.72	0.94	0.72	0.82	0.53	0.61	0.63	0.96	0.97	0.81	0.95	-0.45	0.93		0.91	-0.23	0.37	0.38
Intangible Assets	0.99	0.85	0.93	0.95	0.91	0.81	0.89	0.82	0.76	0.99	0.76	0.94	0.67	0.71	0.77	0.98	0.93	0.88	0.96	-0.51	0.97	0.91		-0.36	0.5	0.51
Good Will	-0.4	-0.48	-0.38	-0.46	-0.29	-0.26	-0.7	-0.38	-0.2	-0.4	-0.2	-0.64	-0.9	-0.59	-0.32	-0.33	-0.24	-0.36	-0.29	0.11	-0.3	-0.23	-0.36		-0.97	-0.97
Common Stock Total Equity	0.54	0.6	0.51	0.6	0.42	0.35	0.79	0.46	0.34	0.54	0.34	0.74	0.98	0.63	0.45	0.47	0.38	0.5	0.42	-0.14	0.43	0.37	0.5	-0.97		1.0
Common Stock	0.55	0.61	0.52	0.61	0.43	0.36	0.8	0.46	0.35	0.55	0.35	0.75	0.98	0.64	0.46	0.48	0.39	0.51	0.43	-0.14	0.44	0.38	0.51	-0.97	1.0

Click cells to compare fundamentals

US Physicalrapy Account Relationship Matchups

US Physicalrapy fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	560.8M	594.4M	749.4M	858.2M	1.0B	1.1B
Other Current Liab	30.9M	59.7M	45.7M	37.4M	55.3M	58.1M
Total Current Liabilities	60.6M	93.5M	83.5M	85.5M	102.2M	107.3M
Total Stockholder Equity	240.3M	276.2M	295.6M	315.8M	476.2M	500.0M
Property Plant And Equipment Net	103.7M	103.3M	119.4M	127.8M	129.5M	136.0M
Net Debt	114.3M	78.1M	194.5M	263.7M	105.8M	111.1M
Retained Earnings	184.4M	212.0M	223.6M	232.9M	223.8M	235.0M
Accounts Payable	2.5M	1.3M	6.5M	6.5M	3.9M	4.1M
Cash	23.5M	32.9M	28.6M	31.6M	152.8M	160.5M
Non Current Assets Total	475.5M	506.7M	654.3M	746.9M	794.7M	834.4M
Cash And Short Term Investments	23.5M	32.9M	28.6M	31.6M	152.8M	160.5M
Net Receivables	56.1M	50.9M	62.4M	68.6M	71.8M	75.4M
Common Stock Shares Outstanding	12.8M	12.8M	12.9M	13.0M	14.2M	12.9M
Liabilities And Stockholders Equity	560.8M	594.4M	749.4M	858.2M	1.0B	1.1B
Other Current Assets	5.8M	3.8M	4.2M	11.1M	8.7M	9.2M
Other Stockholder Equity	55.8M	64.0M	71.9M	78.7M	249.5M	261.9M
Total Liab	181.4M	184.4M	297.0M	373.6M	375.8M	394.6M
Property Plant And Equipment Gross	103.7M	103.3M	97.9M	208.0M	214.4M	225.1M
Total Current Assets	85.4M	87.6M	95.2M	111.3M	233.4M	245.0M
Short Long Term Debt Total	137.8M	111.0M	223.1M	295.3M	258.6M	271.5M
Non Currrent Assets Other	1.5M	1.5M	(28.7M)	(26.4M)	158.0K	165.9K
Non Current Liabilities Total	120.8M	90.9M	213.5M	288.1M	273.7M	287.3M
Short Term Debt	27.2M	32.4M	31.3M	41.6M	42.9M	45.1M
Intangible Assets	52.6M	56.3M	86.4M	108.8M	109.7M	115.2M
Good Will	317.7M	345.6M	434.7M	494.1M	509.6M	484.1M
Common Stock Total Equity	148K	149K	150K	151K	173.7K	144.3K
Common Stock	149K	150K	151K	152K	172K	147.0K
Other Assets	1.5M	14.1M	1.6M	1.6M	1.9M	2.1M
Long Term Debt	50.4M	16.6M	117.6M	175.8M	139.0M	145.9M
Property Plant Equipment	22.1M	21.7M	119.4M	127.8M	146.9M	154.3M
Other Liab	10.2M	12.3M	21.7M	34.3M	39.5M	41.5M
Net Tangible Assets	7.7M	6.6M	(225.5M)	(287.1M)	(258.4M)	(245.4M)
Noncontrolling Interest In Consolidated Entity	930K	1.4M	1.5M	1.6M	1.4M	1.3M
Retained Earnings Total Equity	167.4M	184.4M	212.0M	224.4M	258.1M	158.3M
Long Term Debt Total	38.4M	50.4M	16.6M	117.6M	135.2M	142.0M

Currently Active Assets on Macroaxis

MSFT	Microsoft
GM	General Motors
CRM	Salesforce
MSFT	Microsoft
GOOG	Alphabet Inc Class C

When determining whether US Physicalrapy offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of US Physicalrapy's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Us Physicalrapy Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Us Physicalrapy Stock:

How To Invest In USPH

Details

Is USPH Stock a good investment?

Details

What is US Physicalrapy's Net Worth?

Details

Largest Health Care Providers & Services Companies

View

Largest Health Care Equipment & Services Companies

View

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in US Physicalrapy. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey.

For more detail on how to invest in USPH Stock please use our How to Invest in US Physicalrapy guide.

You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.

Complementary Tools for USPH Stock analysis

When running US Physicalrapy's price analysis, check to measure US Physicalrapy's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy US Physicalrapy is operating at the current time. Most of US Physicalrapy's value examination focuses on studying past and present price action to predict the probability of US Physicalrapy's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move US Physicalrapy's price. Additionally, you may evaluate how the addition of US Physicalrapy to your portfolios can decrease your overall portfolio volatility.

	Portfolio Anywhere Track or share privately all of your investments from the convenience of any device
	Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios
	Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments
	Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
	Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets
	Analyst Advice Analyst recommendations and target price estimates broken down by several categories
	Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments
	Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
	Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios.
	Technical Analysis Check basic technical indicators and analysis based on most latest market data
	Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format

Is US Physicalrapy's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of US Physicalrapy. If investors know USPH will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about US Physicalrapy listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.19)

Dividend Share

1.73

Earnings Share

1.16

Revenue Per Share

41.242

Quarterly Revenue Growth

0.048

The market value of US Physicalrapy is measured differently than its book value, which is the value of USPH that is recorded on the company's balance sheet. Investors also form their own opinion of US Physicalrapy's value that differs from its market value or its book value, called intrinsic value, which is US Physicalrapy's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because US Physicalrapy's market value can be influenced by many factors that don't directly affect US Physicalrapy's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between US Physicalrapy's value and its price as these two are different measures arrived at by different means. Investors typically determine if US Physicalrapy is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, US Physicalrapy's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

USPH Net Receivables vs Deferred Long Term Liab Analysis

Net Receivables vs Deferred Long Term Liab

Net Receivables vs Deferred Long Term Liab Correlation Analysis

Correlation Coefficient

Net Receivables

Deferred Long Term Liab

US Physicalrapy fundamental ratios Correlations

US Physicalrapy Account Relationship Matchups

High Positive Relationship

High Negative Relationship

US Physicalrapy fundamental ratios Accounts

Currently Active Assets on Macroaxis

Complementary Tools for USPH Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Non Current Assets Total	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Cash
Common Stock	+ 1.0	Common Stock Total Equity
Intangible Assets	+ 0.99	Total Assets
Short Term Debt	+ 0.99	Property Plant And Equipment Net
Intangible Assets	+ 0.99	Non Current Assets Total

Common Stock	- 0.97	Good Will
Common Stock Total Equity	- 0.97	Good Will
Good Will	- 0.9	Common Stock Shares Outstanding
Non Currrent Assets Other	- 0.85	Accounts Payable
Non Currrent Assets Other	- 0.84	Net Debt
Good Will	- 0.7	Retained Earnings